Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 (Q93221320)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 April 2020
edit
Language Label Description Also known as
English
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
scientific article published on 17 April 2020

    Statements

    Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 (English)
    181
    0 references
    905-913.e7
    0 references
    4
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit